Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling.

Source:http://linkedlifedata.com/resource/pubmed/id/18342836

Biochem. Pharmacol. 2008 May 1 75 9 1697-705

Download in:

View as

General Info

PMID
18342836